Front & Center

Aligning Hub Services to Optimize Patient, Prescriber and Payer Experiences

April 08, 2019

Sponsored Content

Biopharma companies see a need to provide the same kind of patient access and hub services that patients, prescribers and payers have come to expect. But their design must evolve along to get patients on treatments quickly to maximize their outcome, commitment and satisfaction with care.

Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products

April 08, 2019

Sponsored Content

How biopharma companies can pursue multiple channels to enhance access to segmented markets.

Accent on Accessibility

December 08, 2017

Sponsored Content

Program provides effective, cost-efficient way to help patients overcome affordability barriers and obtain the critical medicines they need.

Digital Engagement and Patient Support Programs

November 06, 2017

Sponsored Content

How can technology be truly patient-centric?

The Future of EIM, OpenText and Documentum

June 23, 2017

Sponsored Content

A conversation with Adam Howatson, CMO, OpenText

Patient Support Services - A Model for the Middle

May 11, 2017

At the recent CBI Patient Assistance and Access Programs conference in Baltimore, Doyle elaborated on issues related to patient access and education that are causing currents in the traditional patient support models.

March 2017: Big Data, Big Opportunity in Life Sciences

March 01, 2017

Sponsored Content

The big data transformation is poised to seep through the life sciences universe, promising to eliminate hundreds of billions of dollars of annual costs in the U.S. biopharmaceutical segment alone.

January 2017: Setting the Pace for the Patient Journey

January 01, 2017

Sponsored Content

How Triplefin’s suite of hub-based e-solutions and customized investments in the “human touch” are outrunning the clock on prior authorization claims-a key source of delays in patient speed to therapy.

January 2017: Banking on Distribution

January 01, 2017

Q&A with AmerisourceBergen's top brass.

January 2017: Small-Company Attention, Big-Company Resources

January 01, 2017

Sponsored Content

Gayle Johnston explains what makes CuraScript SD uniquely able to serve its broad range of customers.

December 2016: Digital and Human Touch Define Next-Generation Hub

December 22, 2016

Sponsored Content

In the battle to differentiate a drug from others in the same therapeutic class, it's keeping an "incisive edge" around services delivery that counts.

December 2016: Streamline Trial Operations with Cloud Opportunities

December 21, 2016

Sponsored Content

eTMG applications provide a strategic asset in the drive for greater efficiency in clinical trials.

December 2016: Orchestrated Customer Engagement

December 20, 2016

Sponsored Content

Building trust to build results starts at the top.

October 2016: Seizing the Commercial Opportunity from Big Data in Life Sciences

October 01, 2016

Sponsored Content

Life sciences: the time is now for a comprehensive big data strategy.

October 2016: Wisdom for the Journey

October 01, 2016

Sponsored Content

In patient support programs, success-and your ROI-rests on making that vital connection between technology and the human touch.

September 2016: Your Hub is Your Secret Weapon to Improve Outcomes

September 01, 2016

Sponsored Content

Hubs can be the secret weapon to providing customized solutions to the industry-wide challenge of improving patient outcomes.

May 2016: The Future of Hub Services: Higher Touch, Less Complexity

May 01, 2016

Sponsored Content

As competition in a diversifying specialty drug business rises to fiver pitch, manufacturers are seeking new ways to differentiate the product servicing model to help their brands stand out. Triplefin's Hub-Lite™ program is adapting to these new expectations with a customized set of services geared to specialty's biggest growth segment: mid-range therapies with higher price tags than traditional retail pharmacy but significantly lower than high-end specialty pharma.

April 2016: The Goldilocks Hub

April 01, 2016

Sponsored Content

The gap is continually growing between high-priced specialty therapies and retail pharmaceuticals. At CBI’s 6th Annual Hub and SPP Model Optimization Conference in Philadelphia this February, Triplefin’s Myra Reinhardt, Vice President of Product Strategy, discussed how Hub services can be tailored to fit “just right” for brands with price points and patient service requirements that are neither too big nor too small.